Motus GI to Release Third Quarter 2020 Results and Provide a Business Update on November 12
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) will release its Q3 2020 financial results on November 12, 2020, after market close. A conference call will follow at 4:30 p.m. ET to discuss the results and corporate updates. The company specializes in endoscopy solutions aimed at improving clinical outcomes for gastrointestinal conditions. Interested parties can access the conference call via phone or webcast, with a replay available on the website for 90 days post-event.
Positive
- Company will provide updates on corporate developments during the conference call.
- Scheduled release of Q3 financial results indicates ongoing transparency and communication with investors.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MOTS declined 1.72%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
FORT LAUDERDALE, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its third quarter 2020 financial results on Thursday, November 12, 2020, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | |
| Date and Time: | Thursday, November 12th at 4:30 p.m. ET |
| Domestic: | 877-407-0792 |
| International: | 201-689-8263 |
| Passcode: | 13711588 |
| Webcast: | www.motusgi.com or http://public.viavid.com/index.php?id=141815 |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com
FAQ
When will Motus GI release its Q3 2020 financial results?
What time is the Motus GI conference call for Q3 results?
How can I access the Motus GI financial results conference call?
Where can I find the replay of the Motus GI conference call?
